Human somatic cells have a mortal phenotype that is under stringent ge
netic control and is dominant over unlimited proliferation. Reversal o
f this phenotype (immortality) may be required for tumour growth. Soma
tic cell division is accompanied by a decrease in telomeric DNA result
ing in progressively shorter telomeres, a process that has been implic
ated in the control of the proliferative lifespan of cells. Conversely
, telomere stabilization and expression of telomerase, the enzyme that
elongates telomeric DNA, have been proposed as crucial to cell immort
alization and tumour growth. This review discusses the data supporting
this hypothesis, focusing on human cell, and addresses their implicat
ions for the management of cancer.